Abstract
Despite the involvement in diverse physiological process and pleiotropic expression profile, the molecular functions of Nur77 are not likely to be fully elucidated. From the effort to find a novel function of Nur77, we detected molecular interaction between Nur77 and PKC. Details of interaction revealed that C-terminal ligand binding domain (LBD) of Nur77 specifically interacted with highly conserved glycine-rich loop of PKC required for catalytic activity. This molecular interaction resulted in inhibition of catalytic activity of PKCtheta by Nur77. C-terminal LBD of Nur77 is sufficient for inhibiting the phosphorylation of substrate by PKCtheta. Ultimately, inhibition of catalytic activity by Nur77 is deeply associated with repression of PKC-mediated activation of AP-1 and NF-kappaB. Therefore, these findings demonstrate a novel function of Nur77 as a PKC inhibitor and give insights into molecular mechanisms of various Nur77-mediated physiological phenomena.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Catalytic Domain / physiology
-
Cell Line
-
DNA-Binding Proteins / chemistry*
-
DNA-Binding Proteins / metabolism
-
DNA-Binding Proteins / physiology*
-
Humans
-
Jurkat Cells
-
Mice
-
Mice, Transgenic
-
Nuclear Receptor Subfamily 4, Group A, Member 1
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / metabolism*
-
Protein Kinase C / physiology
-
Receptors, Cytoplasmic and Nuclear / chemistry*
-
Receptors, Cytoplasmic and Nuclear / metabolism
-
Receptors, Cytoplasmic and Nuclear / physiology*
-
Receptors, Steroid / chemistry*
-
Receptors, Steroid / metabolism
-
Receptors, Steroid / physiology*
-
Transcription Factors / chemistry*
-
Transcription Factors / metabolism
-
Transcription Factors / physiology*
-
Two-Hybrid System Techniques
Substances
-
DNA-Binding Proteins
-
NR4A1 protein, human
-
Nr4a1 protein, mouse
-
Nuclear Receptor Subfamily 4, Group A, Member 1
-
Receptors, Cytoplasmic and Nuclear
-
Receptors, Steroid
-
Transcription Factors
-
Protein Kinase C